Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 6/20 | 0.42 |
| ▸ | ADRB1 | P08588 | 6/20 | 0.42 |
| ▸ | ADRB3 | P13945 | 5/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9749844 | 0.90 | ADRB2 (0.47) | ADRB2ADRB1ADRB3OPRK1MEN1 | |
| SCHEMBL10993872 | 0.89 | ADRB2 (0.34) | ADRB2ADRB1ADRB3OPRK1MEN1 | |
| SCHEMBL9750424 | 0.87 | ADRB2 (0.49) | ADRB2ADRB1ADRB3CYP1A2CYP2D6 | |
| SCHEMBL10997750 | 0.84 | ADRB2 (0.40) | ADRB2ADRB1ADRB3CYP1A2CYP2D6 | |
| SCHEMBL10993894 | 0.83 | ADRB2 (0.43) | ADRB2ADRB1ADRB3 | |
| SCHEMBL10977877 | 0.80 | ADRB2 (0.44) | ADRB2ADRB1ADRB3CYP1A2CYP2D6 | |
| SCHEMBL9749339 | 0.80 | ADRB2 (0.45) | ADRB2ADRB1ADRB3 | |
| SCHEMBL10980202 | 0.80 | KDM4E (0.32) | ADRB2ADRB1ADRB3CYP1A2CYP2D6 | |
| SCHEMBL9749947 | 0.78 | ADRB2 (0.45) | ADRB2ADRB1ADRB3 | |
| SCHEMBL10992310 | 0.78 | ADRB2 (0.36) | ADRB2ADRB1ADRB3OPRK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0131006-B1 | ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1992-06-10 | — | — | EP | disclosed |
| EP-0131006-A4 | ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES. | AMERICAN HOSPITAL SUPPLY CORP (US) | 1985-06-06 | — | — | EP | disclosed |
| US-4508725-A | BETA-ADRENERGIC BLOCKING AGENTS; GLAUCOMA TREATMENT | AMERICAN HOSPITAL SUPPLY CORPORATION (US) | 1985-04-02 | — | — | US | disclosed |
| EP-0131006-A1 | ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES. | AMERICAN HOSPITAL SUPPLY CORP (US) | 1985-01-16 | — | — | EP | disclosed |
| WO-1984002525-A1 | ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES | AMERICAN HOSPITAL SUPPLY CORP (US) | 1984-07-05 | — | — | WO | disclosed |